The effect of airflow limitation on the cause of death in patients with COPD

Abstract

COPD is characterized by airflow limitation that is usually progressive. The present study investigated the cause of death and the effect of airflow limitation on all-cause mortality in COPD patients. A prospective cohort of 600 COPD patients were followed for 3 years. Patients in the Global Initiative for Chronic Obstructive Lung Disease (GOLD) stage 2 (32.7%), GOLD 3 (48.1%), or GOLD 4 (19.1%). Overall, 117 patients died (19.6%). Deaths were due to respiratory failure (29%), cardiovascular disease (25.6%), cancer (17.9%), infection (11%), gastrointestinal disease (9.4%), and other causes (6.7%). According to the Cox regression analysis, the following independent factors were related to mortality: age (years), hazards ratio (HR) 1.046 (confidence interval [CI] 95% 1.021, 1.072); current smoking status, HR 1.535 (CI 95% 1.003, 2.350); cancer, HR 7.172 (CI 95% 4.515, 11.395); cardiovascular disease, HR 2.623 (CI 95% 1.821, 3.778); severe airflow limitation (GOLD 4), HR 2.378 (CI 95% 1.605, 3.525); and highest quartile of acute exacerbations, HR 1.852 (CI 95% 1.236, 2.775). The present study shows that severe airflow limitation, current smoking status, the presence of cardiovascular disease, cancer, and a high frequency of acute exacerbations have an independent negative impact on the prognosis of COPD patients.

References

Garcia-Aymerich J. , Farrero E. , Felez MA , Izquierdo J. , Marrades RM , Anto JM Risk factors of readmisión to hospital for a COPD exacerbation: a prospective study . Thorax 2003; 58: 100-105.

Izquierdo Alonso JL , Arroyo-Espliguero R. EPOC y riesgo cardiovascular . Arch Bronconeumol 2005; 41: 410-412.

Mannino DM , Homa DM , Akinbami LJ , Ford ES , Redd SC Chronic obstructive pulmonary disease surveillance-United States, 1971-2000 . MMWR Surveill Summ 2002; 51: 1-16.

Mannino DM Chronic obstructive pulmonary disease: definition and epidemiology . Respir Care 2003; 48: 1185-1191.

Soriano JB , Izquierdo Alonso JL EPOC en la vida y en la muerte. Arch Bronconeumol 2006; 42: 421-422.

Fuhrman C. , Jougla E. , Nicolau J. , Eilstein D. , Delmas MC Deaths from chronic obstructive pulmonary disease in France, 1979-2002: a multiple cause analysis. Thorax 2006; 61: 930-934.

Mannino DM , Watt G. , Hole D. , et al. The natural history of chronic obstructive pulmonary disease . Eur Respir J 2006; 27: 627-643.

Fabbri L. , Pauwels RA , Hurd SS ; GOLD Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD Executive Summary updated 2003. COPD 2004; 1: 105-141.

Hansell AL , Walk JA , Soriano JB What do chronic obstructive pulmonary disease patients die from? A multiple cause coding analysis. Eur Respir J 2003; 22: 809-814.

10.

Vestbo J. , Hansen EF Airway hyperresponsiveness and COPD mortality. Thorax 2001, 56: ii11-ii14.

11.

Anthonisen NR , Wright EC , Hodgkin JE Prognosis in chronic obstructive pulmonary disease. Am Rev Respir Dis 1986; 133: 14-20.

12.

Nocturnal Oxygen Therapy Trial Group. Continuos or nocturnal oxygen therapy in hypoxemic chronic obstructive pulmonary disease: a clinical trial . Ann Intern Med 1980; 93: 391-398.

13.

Incalzi RA , Fuso L. , De Rosa M. , et al. Co-morbidity contributes to predict mortality of patients with chronic obstructive pulmonary disease. Eur Respir J 1997; 10: 2794-2800.

14.

Landbo C. , Prescott E. , Lange P. , Vestbo J. , Almdal TP Prognostic value of nutritional sattus in chronic obstructive pulmonary disease . Am J Respir Crit Care Med 1999; 160:1856-1861.

15.

Soler-Cataluña JJ , Martínez-García MA , Román Sánchez P. , Salcedo E. , Navarro M. , Ochando R. Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease. Thorax 2005 ; 60: 925-931.

16.

Casanova C. , Cote C. , de Torres JP , et al. Inspiratory-to-total lung capacity ratio predicts mortality in patients with chronic obstructive pulmonary disease . Am J Respir Crit Care Med 2005; 171: 591-597.

17.

Celli BR , Cote CG , Marín JM , et al. The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 2004; 350: 1005-1012.

18.

Alfageme I. , Vazquez R. , Reyes N. , et al. Clinical efficacy of anti-pneumococcal vaccination in patients with COPD. Thorax 2006; 61: 189-195.

19.

Greene HL , Richardson DW , Barker AH , et al. Classification of deaths after myocardial infarction as arrhythmic or nonarrhythmic (the Cardiac Arrhythmia Pilot Study). Am J Cardiol 1989; 63: 1-6.

20.

Martinez FJ , Foster G. , Curtis JL , et al. for the NETT Research Group. Predictors of mortality in patients with emphysema and severe airflow obstruction . Am J Respir Crit Care Med 2006; 173: 1326-1334.

21.

Sunyer J. , Anto JM , McFarlane D. , et al. Sex differences in mortality of people who visited emergency rooms for asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1998; 158: 851-856.

22.

Ringbaek T. , Seersholm N. , Viskum K. Standardised mortality rates in females and males with COPD and asthma. Eur Respir J 2005 ; 25: 891-895.

23.

Anthonisen NR , Skeans MA , Wise RA , et al. Lung Health Study Research Group. The effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trial . Ann Intern Med 2005; 142: 233-239.

24.

Soriano JB , Visick GT , Muellerova H. , Payvandi N. , Hansell AL Patterns of comorbidities in newly diagnosed COPD and asthma in primary care . Chest 2005; 128: 2099-2107.

25.

Sin DD , Anthonisen NR , Soriano JB , Agusti AG Mortality in COPD: role of comorbidities. Eur Respir J 2006; 28: 1245-1257.

26.

Huiart L. , Ernst P. , Suissa S. Cardiovascular morbidity and mortality in COPD. Chest 2005; 128: 2640-2646.

27.

McGarvey LP , John M. , Anderson JA , Zvarich M. , Wise RA Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee. Thorax 2007; 62: 411-415.

28.

Patel IS , Seemungal TAR , Wilks M. , Lloyd-Owen SJ , Donaldson GC , Wedzicha JA Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations. Thorax 2002; 57: 759-764.

29.

Wedzicha JA , Donaldson GC Exacerbations of chronic obstructive pulmonary disease. Respir Care 2003; 48: 1204-1213.

30.

Mannino DM , Brown C. , Giovino GA Obstructive lung disease deaths in the United States from 1979 through 1993: an analysis using multiple-cause mortality data. Am J Respir Crit Care Med 1997; 156: 814-818.